Publications
-
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.
Ho AS,
Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE, Sunwoo JB, Sirjani D, Hara W, Yao M.
Cancer.
2013;
119
(7):
1349-56
-
Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
Bazan JG,
Koong AC, Kapp DS, Quon A, Graves EE, Loo BW, Chang DT.
J Nucl Med.
2013;
54
(1):
27-32
-
Comparison of MRI and ¹⁸F-NaF PET/CT in patients with patellofemoral pain.
Draper CE,
Quon A, Fredericson M, Besier TF, Delp SL, Beaupre GS, Gold GE.
J Magn Reson Imaging.
2012;
36
(4):
928-32
-
Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy.
Witteles RM,
Keu KV, Quon A, Tavana H, Fowler MB.
J Card Fail.
2012;
18
(10):
804-9
-
Initial investigation of ¹⁸F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery.
Quon A,
Dodd R, Iagaru A, de Abreu MR, Hennemann S, Neto JM, Sprinz C.
Eur J Nucl Med Mol Imaging.
2012;
39
(11):
1737-44
-
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Abelson JA,
Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW.
Lung Cancer.
2012;
78
(3):
219-24
-
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.
Lee P,
Bazan JG, Lavori PW, Weerasuriya DK, Quon A, Le QT, Wakelee HA, Graves EE, Loo BW.
Clin Lung Cancer.
2012;
13
(1):
52-8
-
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
Gevaert O,
Xu J, Hoang CD, Leung AN, Xu Y, Quon A, Rubin DL, Napel S, Plevritis SK.
Radiology.
2012;
264
(2):
387-96
-
Patients with patellofemoral pain exhibit elevated bone metabolic activity at the patellofemoral joint.
Draper CE,
Fredericson M, Gold GE, Besier TF, Delp SL, Beaupre GS, Quon A.
J Orthop Res.
2012;
30
(2):
209-13
-
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Chennupati SK,
Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT.
Am J Clin Oncol.
2012;
35
(4):
334-9
-
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Jayachandran P,
Pai RK, Quon A, Graves E, Krakow TE, La T, Loo BW, Koong AC, Chang DT.
Int J Radiat Oncol Biol Phys.
2012;
84
(2):
471-7
-
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.
Nair VS,
Gevaert O, Davidzon G, Napel S, Graves EE, Hoang CD, Shrager JB, Quon A, Rubin DL, Plevritis SK.
Cancer Res.
2012;
72
(15):
3725-34
-
18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
Zissen MH,
Kunz P, Subbarayan M, Chin FT, Conti PS, Fisher GA, Quon A.
Nucl Med Commun.
2011;
32
(5):
343-7
-
Pattern of 18F-FDG uptake in the spinal cord in patients with non-central nervous system malignancy.
Do BH,
Mari C, Tseng JR, Quon A, Rosenberg J, Biswal S.
Spine (Phila Pa 1976).
2011;
36
(21):
E1395-401
-
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
Murphy JD,
La TH, Chu K, Quon A, Fischbein NJ, Maxim PG, Graves EE, Loo BW, Le QT.
Int J Radiat Oncol Biol Phys.
2011;
80
(2):
514-21
-
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Kozak MM,
Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, Wakelee HA, Loo BW.
J Thorac Oncol.
2011;
6
(5):
920-6
-
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.
Horning SJ,
Juweid ME, Schöder H, Wiseman G, McMillan A, Swinnen LJ, Advani R, Gascoyne R, Quon A.
Blood.
2010;
115
(4):
775-7; quiz 918
-
Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.
Kao DP,
Witteles RM, Quon A, Wu JC, Gambhir SS, Fowler MB.
J Am Coll Cardiol.
2010;
55
(9):
926-7
-
Simulations of virtual PET/CT 3-D bronchoscopy imaging using a physical porcine lung-heart phantom.
Yerushalmi D,
Mullick R, Quon A, Fahrig R, Pelc NJ, Fann JI, Gambhir SS.
Mol Imaging Biol.
2009 Jul-Aug;
11
(4):
275-82
-
Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J,
Quon A, Humke E, Ford JM, Koong AC.
Clin Nucl Med.
2009;
34
(5):
312-3
-
Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.
Mittra E,
El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, Iagaru A.
Eur J Nucl Med Mol Imaging.
2009;
36
(12):
1952-9
-
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Zissen MH,
Quon A.
Eur J Nucl Med Mol Imaging.
2009;
36
(9):
1527
-
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
La TH,
Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW, Le QT.
Int J Radiat Oncol Biol Phys.
2009;
74
(5):
1335-41
-
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A,
Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS.
J Nucl Med.
2009;
50
(4):
501-5
-
Positron emission tomography/computed tomography: the current technology and applications.
Mittra E,
Quon A.
Radiol Clin North Am.
2009;
47
(1):
147-60
-
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
Chang DT,
Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC.
Cancer.
2009;
115
(3):
665-72
-
(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
Iagaru A,
Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS.
Hell J Nucl Med.
2008 Sep-Dec;
11
(3):
153-6
-
123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma.
Iagaru A,
Peterson D, Quon A, Dutta S, Twist C, Daghighian F, Gambhir SS, Albanese C.
Mol Imaging Biol.
2008 Jan-Feb;
10
(1):
19-23
-
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Iagaru AH,
Mittra ES, McDougall IR, Quon A, Gambhir SS.
Nucl Med Commun.
2008;
29
(12):
1046-51
-
Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer.
Schellenberg D,
Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC.
Int J Radiat Oncol Biol Phys.
2008;
72
(3):
678-86
-
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.
Quon A,
Chang ST, Chin F, Kamaya A, Dick DW, Loo BW, Gambhir SS, Koong AC.
Eur J Nucl Med Mol Imaging.
2008;
35
(3):
527-31
-
PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy.
Eslamy HK,
Quon A.
Clin Nucl Med.
2008;
33
(12):
864-5
-
2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
Iagaru A,
Quon A, Johnson D, Gambhir SS, McDougall IR.
Mol Imaging Biol.
2007 Jan-Feb;
9
(1):
50-7
-
Advances in metabolic imaging for surgical oncology.
Iagaru A,
Quon A.
Surg Oncol Clin N Am.
2007;
16
(2):
273-92
-
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Quon A,
Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ.
J Nucl Med.
2007:
48 Suppl 1
58S-67S
-
Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Niederkohr RD,
Rosenberg J, Shabo G, Quon A.
Nucl Med Commun.
2007;
28
(9):
688-95
-
Detection of bone metastases: assessment of integrated FDG PET/CT imaging.
Taira AV,
Herfkens RJ, Gambhir SS, Quon A.
Radiology.
2007;
243
(1):
204-11
-
FDG PET/CT detection of a gossypiboma in the neck.
Niederkohr RD,
Hwang BJ, Quon A.
Clin Nucl Med.
2007;
32
(11):
893-5
-
Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.
Patel DA,
Chang ST, Goodman KA, Quon A, Thorndyke B, Gambhir SS, McMillan A, Loo BW, Koong AC.
Technol Cancer Res Treat.
2007;
6
(1):
31-6
-
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R,
Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ.
J Clin Oncol.
2007;
25
(25):
3902-7
-
Metabolic tumor burden predicts for disease progression and death in lung cancer.
Lee P,
Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW.
Int J Radiat Oncol Biol Phys.
2007;
69
(2):
328-33
-
Molecular imaging techniques in body imaging.
Margolis DJ,
Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS.
Radiology.
2007;
245
(2):
333-56
-
No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine.
Niederkohr RD,
Quon A.
Clin Nucl Med.
2007;
32
(4):
302-3
-
RT_Image: an open-source tool for investigating PET in radiation oncology.
Graves EE,
Quon A, Loo BW.
Technol Cancer Res Treat.
2007;
6
(2):
111-21
-
Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A,
Quon A, McDougall IR, Gambhir SS.
Mol Imaging Biol.
2006 Jul-Aug;
8
(4):
212-7
-
"Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy.
Quon A,
Napel S, Beaulieu CF, Gambhir SS.
J Nucl Med.
2006;
47
(7):
1081-7
-
Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT).
Do B,
Mari C, Biswal S, Kalinyak J, Quon A, Gambhir SS.
Ann Nucl Med.
2006;
20
(2):
151-5
-
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Iagaru A,
Quon A, McDougall IR, Gambhir SS.
Clin Nucl Med.
2006;
31
(12):
754-60
-
F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
Vasanawala MS,
Wang Y, Quon A, Gambhir SS.
Clin Nucl Med.
2006;
31
(9):
534-7
-
Sonography of the abnormal parathyroid gland.
Kamaya A,
Quon A, Jeffrey RB.
Ultrasound Q.
2006;
22
(4):
253-62
-
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
Tsai EY,
Taur A, Espinosa L, Quon A, Johnson D, Dick S, Chow S, Advani R, Warnke R, Kohler S, Hoppe RT, Kim YH.
Arch Dermatol.
2006;
142
(5):
577-84
-
Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients.
Fueger BJ,
Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, Ratib O, Phelps ME, Czernin J.
Mol Imaging Biol.
2005 Sep-Oct;
7
(5):
369-76
-
FDG-PET and beyond: molecular breast cancer imaging.
Quon A,
Gambhir SS.
J Clin Oncol.
2005;
23
(8):
1664-73
-
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma.
Allen-Auerbach M,
Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J.
Mol Imaging Biol.
2004 Nov-Dec;
6
(6):
411-6
-
Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease.
Filmont JE,
Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J.
Mol Imaging Biol.
2004 Jan-Feb;
6
(1):
47-54
-
Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
Halpern BS,
Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J.
J Nucl Med.
2004;
45
(5):
797-801
-
Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients.
Filmont JE,
Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J.
Mol Imaging Biol.
2003 Jul-Aug;
5
(4):
232-9
-
Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.
Vranjesevic D,
Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J.
J Nucl Med.
2003;
44
(8):
1238-42
-
Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation.
Filmont JE,
Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C.
Chest.
2003;
124
(2):
608-13
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help